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1074-34 Demographic Parameters Predict Strongly All-Cause 
and Arrhythmic Mortality in High Risk Patients After 
Myocardial Infarction in the Thrombolytic Era: A 
Secondary Analysis of  Surv iva l  Trials 
Yee Guan Yao. Trinh Duong, Martin Bland, Marek Malik, Christian Torp-Pederson, Lars 
Kober, Stuart Connolly, Bradley Marchant, A. John Carom, SL George's Hospital Medical 
School, London, United Kingdom. 
Backround: Risk stratification of patients after myocardial infarction (MI) at high risk of 
mortality remains expensive and disappointing. Demographic features may provide use- 
ful prediction but contemporary information is lacking on their effect on the specific mode 
of mortality after MI in the thrombelytic era, We aim to examine the prognostic values of 
simple baseline demographic factors on specific modes of death after MI. Methods: We 
pooled the individual patient data on 3105 placebo patients (2471M, median age: 65 (23- 
92)) from EMIAT, CAMIAT, SWORD, TRACE & DIAMOND-MI with LVEF_<40% or ventric- 
ular arrhythmia surviving _>45d after MI. Risk factors for mortality up to 2-years were 
examined (Cox regression). Results: After adjustment for drug & study effects: age, pre- 
vious MI/angina, hypertension, diabetes, NYHA class, baseline systolic blood pressure, 
heart rate, and Q wave MI all increased the risk of all-cause & arrhythmic mortality 
(table). Diabetes affects ACM whereas male sex affects AD respectively. Cardiac mortal- 
ity was affected by age, previous MI/angina, heart rate (p< 0.0001) & NYHA class (p< 
0.001). Smoking and atrial fibrillation had no effect. Conclusions: In high-risk post-MI 
patients: 1) demographic features are powerful predictors of mortality and identify at risk 
patients further; 2) Demographic variables must be considered when stratifying patients 
for prophylactic antiarrhythmic therapy or designing survival trials. 
Risk factors All-cause mortality Arrhythmic mortality 
HR (95% CI), p-value HR(95% CI), p-value 
Age (^ 10 yr) 1.4 (1.3-1.6), p<0.001 1.3(1.1-1.5), p=O.005 
Males 1.3 (1.0-1.6), p=0.06 1.6(1.1-2.4), p=0.001 
Previous MI 1.6 (1.3-2.0), p<0.001 1.7(1.3-2.3), p=0.001 
Hypertensive history 1.4 (1.1-1.7), p=0.005 1.7(1.3-2.4), p=0.001 
Angina history 1.6 (1.3-2.0), p<0.001 1.6(1.1-2.2), p=0.007 
Diabetes 1.3 (1.01-1.7), p=0.04 1.3(0.9-1.9), p=0.1 
Systolic BP (^ 10%) 0.9 (0.8-1.0), p=0.002 0.8(0.8-0.9), p<0.001 
Heart rate (^ 10%) 1.14 (1.1-1.2), p<0.001 1.1(1.0-1.2), p=0.009 
NYHA (vs. NYHA 0) : I 1.5 (0.9-2.5) 1.9 (0.9-4.0) 
II 2.3 (1.4-3.8) 3.0 (1.4-6.4) 
III 2.9 (1.6-5.0) 3.5 (1.5-8.0) 
IV 4.1 (2.0-8.5), p<0.001 3.9 (1.2-12.4), p=0.006 
Q-wave 0.7 (0.6-0.8), p<O.001 0.7(0.49-0.92), p=0.01 
1074-35 Assessment of International Differences in 30-Day 
Event of Death and Reinfarction Amongst Patients with  
Acute Coronary Syndromes: Insights from GUSTO IV 
ACS 
William K. Midodzi, Wei-Ching Chang, Yuling Fu, Eric Boersma, J. Cooper, Elliot 
Bamathan, Maarten L. Simoons, Lars Wallentin, E. Magnus Ohman, Paul W. Armstrong, 
University of Alberta, Edmonton, Alberta, Canada. 
Wide variations in management end outcome among countries exist in patients with acute 
coronary syndromes (ACS), but the relative contribution of patient, hospital, and country 
has not been evaluated. We determined if 30-day composite death or myocardial infarction 
(MI) following ACS differ between countries, and quantified the variation attributable to the 
countries. Data from GUSTO IV ACS trial with 7800 patients randomized from 24 countries 
and 458 hospitals were used. 
There were significant inter-country differences in 30-day incidence (%) of death/(re)Ml: the 
overall mean rate and inter-country ranges (%) were 8 [5-14, p=.003]. 30-day rates (%) of 
interventions and clinical events also differed significantly (p<.001) between countries: car- 
diac catheterization (CC), 40 [14-67]; percutaneous coronary intervention (PCI), 19 [5-50]; 
coronary artery bypass grafting (CABG), 11 [4-21]; (re)MI, 6 [2-13]. We used hierarchical 
logistic modeling to partition the variance in the 30-day composite event into patient, hospi- 
tal and country levels. The hospital and country factors explained respectively 7.7% and 
2.5% but after adjusting for significant patient characteristics these were reduced to 5.5% 
and 1.4%. The significant independent predictors at the patient level were: age, prior con- 
gestive heart failure, prior MI, prior CABG, prior use of calcium channel blockers, ST 
depression, and troponin positivity. Inter-country differences in rates of CC, PCI and CABG 
accounted for only 17% of the variance in adjusted composite rates among countries. In 
conclusion, there were significant country differences after adjusting for patient-level cova- 
dates. Adjusted 3O-day composite rates were highest in U.S (OR=1.3 95%CI, 1.1-1.8) and 
lowest in Poland (OR= .7, 95%CI, .5-.9), with study population as reference, but these dif- 
ferances were explained mainly by patient variation across hospitals. 
1074-36 Should CK-MB Measurements Be Abandoned in Acute 
Coronary Syndrome Patients 
Kimberlv C. Yee. Dean E. Smith, Eva M. Kline-Rogers, Yassar AJmanaseer, Eyad 
Akhras, Jeanna V. Cooper, Rajendra H. Mehta, Kim A. Eagle, University of Michigan 
Health Systems, Ann Arbor, Michigan. 
Background: Measurement of troponin I and T have emerged as a useful prognostic 
indicator in acute coronary syndrome (ACS) patients (pts). It is unclear what role CK-MB 
measurement should play in the management of ACS pts. 
Methods: We examined data from ACS pts with no troponin-I elevation and compared 
outcomes between troponin negative pts with and without elevated CK-MBs. Baseline 
demographics, clinical data, and six month follow-up (f/u) information were prospectively 
collected from 1,256 consecutive ACS pts presenting at University of Michigan Hospitals 
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between 1/99 and 12/00. Of those pts, 675 showed no initial elevation in troponin levels; 
CK-MB positive and negative pts were compared using chi-squared analysis. 
Results: Among 675 troponin negative pts, 599 were CK-MB negative (Group A) and 76 
were CK-MB positive (Group B). At six-month f/u, pts in group B showed a trend towards 
higher mortality end higher rates of unexpected cardiac-related rehospitalization. 
Outcome For Troponin Negative ACS Patients 
Event at6 month follow-up Group A (%) Group B (%) p-value 
(n=599) (n=78) 
Death 32(6.9) 9(12.9) 0.11 
Cardiac-related rehospffalization 129(29.7) 27(39.1 ) 0.12 
Stroke 6(1.4) 1 (1.6) 0.92 
MI 23(8.4) 3(7.7) 1.00 
Conclusion: 1) A nonsignificant rend suggests increased risk of cardiac-related rehos- 
pitalization and f/u death in troponin negative, CK-MB positive ACS pts. 2) Further study 
of larger numbers of pts are needed to clarify the prognostic value of CK-MB measure- 
ment compared with clinical and ECG parameters in troponin negative ACS pts, 3) Our 
preliminary data suggests that one rational approach to biomarker use in ACS may be to 
check CK-MB only in troponin negative ACS pts. 
1074-37 Ear ly Ident i f i cat ion  o f  Myocardial Infarction in the 
Emergency Department by a Change in Serum 
Myoglobin 
Susan M, Sallach, John A. Sallach, Michael P. Hudson, James McCord, Henry Ford 
Hospital Detroit, Michigan. 
Background: in patients presenting to the emergency department (ED) with acute myo- 
cardial infarction (AMI), CK-MB and troponin I (cTnl) have insufficient sensitivity at pre- 
sentation, not rising until 3-6 hrs after symptom onset. Myogtebin (Mye) rises as early as 
1-2 hrs after symptom onset in AMI. The change in Myo may be helpful in AMI in cTnl 
negative patients on admission. 
Methods: In 1999, a total of 817 consecutive patients evaluated in the ED at Henry Ford 
Hospital for possible AMI were studied, excluding patients with ST segment elevation. 
Blood was sampled at presentation, 90 rains and 9 hrs measuring Myo, cTnl, and CK-MB 
(Triage Cardiac, Biosite). A final diagnosis of AMI required at least one positive CK-MB 
(>gog/mL), and agreement between two independent cardiologists. Patients with an ini- 
tial normal Myo (<200ng/mL) were subjected to receiver operating characteristic curve 
(ROC) analysis to determine the best cut-point for an absolute Myo change. 
Results: Sixty five (8%) patients were diagnosed with AMI including 23 patients with ini- 
tial normal cTnl. ROC analysis determined that a 0 to 90 mins Myo increase of 20ng/mL 
provided maximal diagnostic utility (area under the curve 0,830). An elevated Myo value 
at 0 hr or a change in Myo at 90 rains produced 100% sensitivity and negative predictive 
value for AMI. The specificity for the change in Myo at 90 rains was 88%. 
Conclusion: In ED patients with normal cTnl values at 0 hr, a change in Myo provides a 
highly accurate AMI diagnosis within 90 mins. 
Myoblobln Change Over 90 minutes 
0 hour 90 minutes Myo change 
0-90 minutes 
Median Myo (ng/mL) 268 395 127 
AMI patients with negative cTnl 
n=23 
Median Myo (ng/mL) 86 76 -10 
non-cardiac diagnoses 
n=395 
p-value <0.001 <0.001 0.005 
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1075-27 Improved Outcome of Acute ST-Segment Elevation 
Myocardial Infarction in Patients With Prior Coronary 
Artery Bypass Surgery Treated With Combination 
Reduced Fibrinolytic Therapy and Platelet Glycoprotein 
l ib/I l ia Inh ib i t ion  
Debabrata Mukhedee. Hitinder Gurm, W,H,Wilsen Tang, Marco Roffi, Kathy Wolski, 
David J. Moliterno, Victor Guetta, Diego Ardissine, Christopher Bode, Gabriel Stag, A 
Michael Lincoff, Eric J. Topoi, University of Michigan, Ann Arbor, Michigan, Cleveland 
Clinic Foundation, Cleveland, Ohio. 
Background: Acute ST-segment elevation myocardial infarction (MI) in patients with pre- 
vious coronary artery bypass surgery (CABG) is associated with lower reperfusion rates 
and worse outcome following fibrinolytic therapy. The efficacy of a combination strategy 
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(reduced fibrinolytic + ptatelet glycoprotein lib/Ilia inhibitor) in this setting is unknown. 
Methods: In the GUSTO V trial, 553 patients with history of prior CABG were treated with 
standard-dose retaplase (n=273) or haft-dose reteplase and full--dose aboiximab (n=280) 
in the first 6 h of evolving ST-segment elevation myocardial infarction. Results: Mortality 
at 30-days was significantly higher in patients with prior CABG compared to patients 
without prior CABG (6.85% vs 5.6%, p=0.003). Despite having more diabetes, hypercho- 
lesterolemia nd longer time to treatment, patients with previous CABG undergoing com- 
bination therapy had fewer episodes of recurrent ischemia, reinfarction, with the 
combination than with rataplase alone, and less need for urgent revascularizafion. Con- 
clusions: In the GUSTO V trial patients with prior CABG had significantly higher event 
rates compared to patients without CABG. As in the overall trial, combination therapy in 
patients with prior CABG led to a consistent reduction in key secondary complications of 
myocardial infarction including recurrent ischemia, reinfarction, and urgent revasculariza- 
tion. 
Clinical outcomes in patients with prior CABG 
CABG CABG No CABG No CABG 
(Retaplase)(R~eplase+(Reteplase) (Retaplase+ 
n=273 Abciximab) n=7924 Abciximab)n=7981 
n=280 
Age 65±10 66±9.7 61±12.2 62±12.1 
Diabetes 20.7% 26.1% 15.7% 15.8% 
Hypercholestrofemia 53.6% 59.2% 15.1% 16.1% 
Time to treatment (hours) 2.9 ±1.7 3.2 ± 2.4 2.9 ±1.6 3.0 ± 2,1 
Death (7 days) 6.6% 5.7% 4.4% 4.2% 
Daath/MI (7 days) 11.7% 9.6% 7.3% 6.1% 
Death (30 days) 8.8% 8.9% 5.8% 5.4% 
Reinfarction 6.2% 4.6% 3.4% 2.2% 
Urgent revasc (7 day) 16.5% 11.1% 13.8% 10.3% 
Death/MI/urgent revasc (7 day) 24.2% 19.3% 19.1% 15.0% 
Recurrent ischemia 21.6% 14.3%* 12.5% 11,2% 
*p<0.05 
1075-28 Early and Late Survival Following Primary PTCA for 
Acute Myocardial Infarction in Patients With Saphenous 
Vein Graft Occlusion 
Bruce R. Brodie, Thomas Stuckey, Chades Hansen, Denise Munoy, Debra VerSteeg, 
Mark Pulsipher, Navin Gupta, LeBauer Cardiovascular Research Foundation and Moses 
Cone Heart & Vascular Center, Greensboro, North Carolina. 
BACKGROUND: Primary PTCA has improved reperfusion rates in pts with AMI due to 
saphenous vein graft (SVG) occlusion, but procedural results remain suboptimal and the 
long term outlook has not been well defined. 
METHODS: Consecutive pts with AMI treated with primary PTCA from 1984-2000 
(N=1844) were prospectively enrolled in a registry and followed for 10 years. 
RESULTS: Pts with prior bypass surgery(CABG)(N=89) were more often men (81% vs. 
68%, p=0.01), had of prior MI (49% vs. 16%, p<0.001), cardiogenic shock (16% vs. 
7.3%, p=0.004), and 3 vessel CAD (82% vs. 20%, p<0.001), and less anterior MI (28% 
vs. 39%, p=O.04) and lower EF (47% vs. 52%, p=0.001). Pts with prior CABG achieved 
TIMI-3 flow less often (87% vs. 94%, p=0.007) and had higher 30-day mortality (14.6% 
vs. 7.6%, p=0.02). When the infarct artery was a SVG (N=54), TIMI-3 flow was achieved 
less frequently (80% vs. 94%, p<0.001) and 30-day mortality was higher (18.5% vs. 
7.6%, p=0.003). Late survival was worse in pts with SVG occlusion(figure). 
CONCLUSIONS: Pts with AMI due to SVG occlusion have higher early and substantially 
higher late mortality compared with pts with native vessel occlusion. The poor survival 
appears to be due to worse baseline risk profile, worse procedural results, and more 
rapid progression of disease over long term follow up. These should encourage the 
development of new procedural techniques and more aggressive secondary prevention 
in pts with SVG disease and a search for more durable revascularization strategies. 
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1075-29 Clinical end Angiographic Predictors of Abnormal 
Doppler-Derived Flow in the Infarct Related Artery After 
Primary Angioplaety for Acute Myocardial Infarction 
Simon R. Dixon, William W. O'Neill, John A. Fry, Robert D, Safian, James A. Goldstein, 
Cindy L. Grines, Terry R. Bowers, William Beaumont Hospital, Royal Oak, Michigan. 
Background. Abnormal phasic flow in the infarct related artery (IRA) after primary angio- 
plasty is associated with severe microvascular dysfunction and predicts poor recovery of 
left ventricutar function. Clinical and angiographic orrelates of an abnormal flow pattern 
in the IRA after primary angioplasty have not been well defined. 
Methods, Doppler derived coronary blood flow velocity patterns were recorded in the 
IRA after primary angioplasty or stenting in 78 patients with acute MI (mean age 63 ± 13 
JACC March 6, 2002 
yrs) utilizing an intracoronary Doppler wire (FIoWire, Endosonics). Abnormal flow was 
defined by the presence of rapid diastolic deceleration and early systolic flow reversal. 
Results. Fourteen patients (18%) had an abnormal flow pattern in the IRA after interven- 
tion despite an excellent angiographic result (TIMI-3 flow 100% pts, diameter stenosis 
<10%). The IRA was the left anterior descending (LAD) in 55%, right coronary artery in 
33%, and circumflex in 12%. Stenting was performed in 91% patients (POBA 9%). Base- 
line clinical characteristics, time-to-reperfusion from symptom-onset, prior thrembolytic 
therapy, and initial TIMl-flow grade did not correlate with the presence of an abnormal 
flow pattern. Compared to patients with a normal Doppler flow pattern, those with an 
abnormal flow pattern in the IRA after intervention were more likely to have LAD infarc- 
tion (30% vs. 3%, LAD vs. non-LAD, p=0.002), a lower left ventricular ejection fraction 
(35% vs. 47%, p=0.008), and a higher left ventricular end-diastolic pressure (31 vs. 
20mmHg, p<0.001).Concluslon. After primary PTCA, abnormal Doppler-derived phasic 
flow in the IRA is most commonly observed in patients with LAD occlusion. These data 
suggest that studies evaluating novel microvascular reperfusion therapies should prima- 
rily target patients with anterior wall infarction. 
1075-30 Corrected TIMI Frame Count (CTFC) and Quantitative 
Stress Myocardial Perfuslon imaging Defect Score 
Independently Predict Major Adverse Cardiac Events 
Following Successful Primary Angloplasty: A 
Dipyridemole Tc99m Sestamlbi Gated SPECT Imaging 
Study 
Satvendra Gid. Alan Ahlberg, Joseph Mitchel, Michael Gibson, Abdul Alkelyani, Jeffrey J. 
Popma, Deborah Katon, Andrew C. Eisenhauer, Gary V. Heller, Brigham & Women's 
Hospital, Boston, Massachusetts, Hartford Hospital, Hartford, Connecticut. 
Background: During primary angioplasty (PA), prolonged TIMI frame count (CTFC) may 
represent impaired microcirculation. Similarly, stress-induced MPI defects prognosticate 
adverse cardiac events (MACE). 
Methods: To investigate whether automated MPI score and CTFC correlate and predict 
MACE, we studied 58 consecutive pts treated with PA <12 hr of first acute MI (age 55+12 
yr., 74% male, symptom-to-balloon time: 269±72 min). Dipyddamole Tc 99m sestamibi 
MPI was performed 48 hrs post-procedure and at 6 weeks using 3-D MSPECT quantita- 
tive analysis software. Independent core laboratory performed quantitative angiography 
to determine CTFC and lumen dimensions. 
Results: Following PA, stress (28.4+20 vs 20.0~19; p<0.01 ) and rest MPI score (21.9±19 
vs 12.1+15; p<0.01) and LV ejection fraction (EF=47.3±10 vs 53.1+9; p=0.01) improved 
at 6 weeks. 
CTFC (mean 31.4±13) correlated with stress (r=0.79, p<0.0001; see figure) and rest 
(r=0.70, p<0.001) MPI defect score and LVEF (r=0.69, p<0.001). 
At one year, MACE occurred in 9 pts (1 death, 5 MI, 5 target vessel revascutarization). 
In multivariable analysis, MACE was predicted by quantitative stress MPI score [OR 0.54 
95%CI (0.34 - 0.86); p=0.01] and CTFC [OR 1.47 95% CI (1.12 - 1.92); p=0.005] with an 
important interaction between the two [OR 0.98 95%CI (0.97 - 0.99); p=0.01] 
Conclusion: The occurrence of slow flow (CTFC) and high stress MPI defect score fol- 
lowing PA, despite successful epicardial arterial patency, are independently associated 
with increased MACE. 
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1075-43 Role of Abciximab in the Preservation of Myocardial 
Mlcrocirculation During Mechanical Reperfusion for 
Acute ST Segment Elevation Myocardial Infarction 
Mahesh S. Mulumudi. Srinivasa P, Potiuri, Christopher J. White, Ochsner Medical 
Institutions, New Orleans, Louisiana. 
Objective: We investigated the effect of abciximab on myocardial microcirculation follow- 
ing primary coronary intervention for acute ST-segment elevation myocardial infarction 
(STEMI). 
Background: Prompt restoration of both epicardial blood flow and myocardial microcircu- 
lafion are the goals of reperfusion strategies in acute myocardial infarction. Myocardial 
Blush Grade (MBG) has been shown to be an important angiographic tool for the assess- 
ment of myocardial microcirculation reperfusion. Higher blush grades were associated 
with better outcomes. One possible mechanism by which abciximab exerts its beneficial 
